Exploring the Interaction Between Synphilin-1 and Alpha-Synuclein in Parkinson’s Disease
Author Information
Author(s): Asmita Tripathi, Rajkrishna Mondal, Malay Mandal, Tapobrata Lahiri, Manoj Kumar Pal
Primary Institution: Indian Institute of Information Technology Allahabad
Hypothesis
The study investigates how specific mutations in alpha-synuclein affect its interaction with Synphilin-1, contributing to the formation of Lewy Bodies in Parkinson's disease.
Conclusion
The new method, AlphaLarge, successfully predicts the structures of Synphilin-1 and mutated alpha-synuclein, revealing important details about their interactions that could inform therapeutic strategies for Parkinson's disease.
Supporting Evidence
- AlphaLarge outperformed AlphaFold in predicting structures of large proteins.
- The interaction details extracted align with previously reported binding characteristics.
- Binding energy analysis indicates stronger interactions between Synphilin-1 and mutated alpha-synuclein.
Takeaway
This study looks at how two proteins involved in Parkinson's disease fit together, which can help scientists find better medicines to treat the disease.
Methodology
The study used a semi-automatic pipeline called AlphaLarge to predict the structures of large proteins and analyzed their interactions using Protein Mediated Interaction Analysis (PMIA).
Limitations
The study's findings are based on predicted structures, which may not fully capture the complexities of protein interactions in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website